Literature DB >> 2396703

Interleukin 1 alpha and an interleukin 1 beta fragment are somnogenic.

F Obal1, M Opp, A B Cady, L Johannsen, A E Postlethwaite, H M Poppleton, J M Seyer, J M Krueger.   

Abstract

The somnogenic activity of interleukin 1 beta (IL-1 beta) has previously been established. Interleukin 1 alpha (IL-1 alpha) is a distinct gene product that possesses similar biological activities. We report here that IL-1 alpha, like IL-1 beta, has the capacity in rabbits to enhance non-rapid-eye-movement sleep, electroencephalographic slow-wave (0.5-3.5 Hz) voltages, and body temperatures and to inhibit rapid-eye-movement sleep. After IL-1 alpha, sleep remained episodic, and at the doses used no abnormal behavior was observed. Several synthetic IL-1 alpha and IL-1 beta peptides were also tested in vivo for somnogenic and pyrogenic activity and in vitro for their ability to stimulate prostaglandin E2 (PGE2) production by fibroblasts and proliferation of T-cells. Only IL-1 beta-(208-240) enhanced non-rapid-eye-movement sleep and body temperature, although both IL-1 beta-(208-240) and IL-1 alpha-(223-250) stimulated PGE2 production; both of these peptides failed to stimulate T-cell production. In contrast, four other IL-1 peptides were nonpyrogenic and somnogenically inactive yet stimulated T-cell proliferation. We conclude that the components of IL-1 required for sleep and temperature activities are different from those required for T-cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2396703     DOI: 10.1152/ajpregu.1990.259.3.R439

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

Review 1.  Humoral sleep regulation; interleukin-1 and tumor necrosis factor.

Authors:  Kathryn A Jewett; James M Krueger
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

Review 2.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

3.  Sleep disturbance in Moroccan patients with ankylosing spondylitis: prevalence and relationships with disease-specific variables, psychological status and quality of life.

Authors:  Jinane Hakkou; Samira Rostom; Mariam Mengat; Nawal Aissaoui; Rachid Bahiri; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2012-03-24       Impact factor: 2.631

4.  Interleukin-1β (187-207)-induced hyperthermia is inhibited by interleukin-1β (193-195) in rats.

Authors:  Miklós Palotai; Edina Kiss; Zsolt Bagosi; Miklós Jászberényi; Gábor Tóth; Györgyi Váradi; Gyula Telegdy
Journal:  Neurochem Res       Date:  2013-12-13       Impact factor: 3.996

Review 5.  Neuroendocrine Control of Sleep.

Authors:  Philip C Smith; Jessica A Mong
Journal:  Curr Top Behav Neurosci       Date:  2019

6.  Associations of early pregnancy sleep duration with trimester-specific blood pressures and hypertensive disorders in pregnancy.

Authors:  Michelle A Williams; Raymond S Miller; Chunfang Qiu; Swee May Cripe; Bizu Gelaye; Daniel Enquobahrie
Journal:  Sleep       Date:  2010-10       Impact factor: 5.849

7.  Characterization and mechanism of fever induction by interleukin-1 beta.

Authors:  M Hashimoto
Journal:  Pflugers Arch       Date:  1991-12       Impact factor: 3.657

8.  Maternal sleep duration and complaints of vital exhaustion during pregnancy is associated with placental abruption.

Authors:  Chunfang Qiu; Sixto E Sanchez; Bizu Gelaye; Daniel A Enquobahrie; Cande V Ananth; Michelle A Williams
Journal:  J Matern Fetal Neonatal Med       Date:  2014-05-22

9.  Interleukin 1 receptor antagonist blocks somnogenic and pyrogenic responses to an interleukin 1 fragment.

Authors:  M R Opp; A E Postlethwaite; J M Seyer; J M Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  Central infusion of interleukin-1 receptor antagonist blocks the reduction in social behavior produced by prior stressor exposure.

Authors:  Hiroyuki Arakawa; Peter Blandino; Terrence Deak
Journal:  Physiol Behav       Date:  2009-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.